Cabotegravir with rilpivirine for treating HIV-1

Equality Impact Assessment (Guidance development) (PDF 160 KB)

Final draft guidance

Final appraisal document (PDF 267 KB)

Public committee slides (PDF 1.3 MB)

Committee papers (PDF 6.76 MB)

Final stakeholder list (PDF 162 KB)

Equality impact assessment (Scoping) (PDF 119 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 428 KB)

Final scope (PDF 160 KB)

Draft scope pre referral (PDF 167 KB)

Draft matrix pre referral (PDF 162 KB)